| NYHA | New York Heart Association Heart Disease에 대한 Functional Classification &nbs... |
|---|---|
| WDMF | wall-defective microbial forms |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| HIVD | Herniation(Herniated) of Inter-Vertebral Disc - Cervical HIVD &... |
| PEEP | Positive End-Expiratory Pressure ? Ix 1. PaO2 < 60 mmHg, ... |
| DRO | Differential Reinforcement of Other Behaviour |
|---|---|
| MOTT | Mycobacteria Other Than Tuberculosis |
| OND | Other Neurological Diseases |
| SO | significant other |
| AOD | and other drug |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| accole forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| applique forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| asymptomatic coccidioidomycosis | A form of coccidioidomycosis not differentiated clinically from upper respiratory infections of viral or bacterial aetiology; positive skin tests are useful in demonstrating past and present infections; tests for circulating serum antibodies are prognostic as well as diagnostic in some cases. Synonym: asymptomatic coccidioidomycosis. (05 Mar 2000) |
| atypical bacterial forms | Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. (12 Dec 1998) |
| coccidioidomycosis | <chest medicine, microbiology> A fungal infection caused by the fungus Coccidioides immitis. Exists in two forms: primary disease, which is a self-limited respiratory infection (requires no treatment) and a progressive form (diffuse and granulomatous), that can involve almost any part of the body. Approximately 60% of infections cause no symptoms and are identified only by skin testing. Immunocompromised patients (AIDS) are at greatest risk for disseminated disease. Symptoms include cough, anorexia, fever, weight loss and joint pains. Complications include pleural effusion and dissemination. There is a poor prognosis for disseminated disease. Treatment includes amphotericin B for lung infection. Itraconazole and fluconazole are also useful agents. (27 Sep 1997) |
| primary coccidioidomycosis | A disease common in the San Joaquin Valley of California and certain additional areas in the southwestern U.S. As well as the Chaco region of Argentina, caused by inhalation of the arthroconidia of Coccidioides immitis; acute onset of symptoms resemble pneumonia or pulmonary tuberculosis, productive of sputum usually containing spores of the fungus, and accompanied by aches, malaise, severe headache, and occasionally an early erythematous or papular eruption; erythema multiforme or erythema nodosum may appear; the coccidioidin test is positive. Synonym: desert fever, San Joaquin fever, San Joaquin Valley disease, San Joaquin Valley fever, valley fever. (05 Mar 2000) |
| primary extrapulmonary coccidioidomycosis | A rare form of coccidioidomycosis presenting near the site of local trauma with painless firm nodules occurring at one to two weeks, accompanied by regional adenopathy, with spontaneous healing in a few weeks. (05 Mar 2000) |
| secondary coccidioidomycosis | Progressive or disseminated extrapulmonary granulomatous lesions following primary coccidioidomycosis. Synonym: coccidioidal granuloma. (05 Mar 2000) |
| disseminate coccidioidomycosis | A severe, chronic, and progressive form of coccidioidomycosis resulting from rapid dissemination of endospores from the primary site of infection, or from reinfection in a previously sensitised patient, with widespread involvement of the central nervous system, bones, skin, and viscera. (05 Mar 2000) |
| dosage forms | Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include capsules, liniments, ointments, pharmaceutical solutions, powders, tablets, etc. (12 Dec 1998) |
| forms and records control | A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. (12 Dec 1998) |
| forms of DNA i, II and III | Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear. (09 Oct 1997) |
| latent coccidioidomycosis | A form of coccidioidomycosis not differentiated clinically from upper respiratory infections of viral or bacterial aetiology; positive skin tests are useful in demonstrating past and present infections; tests for circulating serum antibodies are prognostic as well as diagnostic in some cases. Synonym: asymptomatic coccidioidomycosis. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|